1. Home
  2. RAPT vs CFFI Comparison

RAPT vs CFFI Comparison

Compare RAPT & CFFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RAPT
  • CFFI
  • Stock Information
  • Founded
  • RAPT 2015
  • CFFI 1927
  • Country
  • RAPT United States
  • CFFI United States
  • Employees
  • RAPT N/A
  • CFFI N/A
  • Industry
  • RAPT Biotechnology: Pharmaceutical Preparations
  • CFFI Major Banks
  • Sector
  • RAPT Health Care
  • CFFI Finance
  • Exchange
  • RAPT Nasdaq
  • CFFI Nasdaq
  • Market Cap
  • RAPT 194.2M
  • CFFI 218.0M
  • IPO Year
  • RAPT 2019
  • CFFI 1998
  • Fundamental
  • Price
  • RAPT $13.18
  • CFFI $71.53
  • Analyst Decision
  • RAPT Buy
  • CFFI
  • Analyst Count
  • RAPT 5
  • CFFI 0
  • Target Price
  • RAPT $33.60
  • CFFI N/A
  • AVG Volume (30 Days)
  • RAPT 117.5K
  • CFFI 10.8K
  • Earning Date
  • RAPT 08-07-2025
  • CFFI 10-28-2025
  • Dividend Yield
  • RAPT N/A
  • CFFI 2.61%
  • EPS Growth
  • RAPT N/A
  • CFFI 32.15
  • EPS
  • RAPT N/A
  • CFFI 7.56
  • Revenue
  • RAPT N/A
  • CFFI $122,075,000.00
  • Revenue This Year
  • RAPT N/A
  • CFFI N/A
  • Revenue Next Year
  • RAPT N/A
  • CFFI N/A
  • P/E Ratio
  • RAPT N/A
  • CFFI $9.43
  • Revenue Growth
  • RAPT N/A
  • CFFI 7.42
  • 52 Week Low
  • RAPT $5.67
  • CFFI $53.14
  • 52 Week High
  • RAPT $26.56
  • CFFI $89.90
  • Technical
  • Relative Strength Index (RSI)
  • RAPT 63.64
  • CFFI 59.59
  • Support Level
  • RAPT $11.19
  • CFFI $70.39
  • Resistance Level
  • RAPT $13.66
  • CFFI $73.00
  • Average True Range (ATR)
  • RAPT 0.75
  • CFFI 1.89
  • MACD
  • RAPT 0.19
  • CFFI -0.01
  • Stochastic Oscillator
  • RAPT 86.53
  • CFFI 75.78

About RAPT RAPT Therapeutics Inc.

RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.

About CFFI C&F Financial Corporation

C&F Financial Corp is an American bank holding company. The company through its subsidiaries offers banking and related financial services to both individuals and businesses. It operates in three business activities: Community Banking, Mortgage Banking, and Consumer Finance. It mainly provides a range of lending activities, which include residential mortgage loans, commercial real estate loans, non-prime automobile lending, land acquisition, and development loans, and consumer loans. The company generates maximum of its revenue from the Community Banking segment.

Share on Social Networks: